Pfizer Income Taxes 2006-2020 | PFE

Pfizer annual/quarterly income taxes history and growth rate from 2006 to 2020. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Pfizer income taxes for the quarter ending September 30, 2020 were $-0.026B, a 100.85% decline year-over-year.
  • Pfizer income taxes for the twelve months ending September 30, 2020 were $-0.213B, a 110.64% decline year-over-year.
  • Pfizer annual income taxes for 2019 were $1.384B, a 96.03% increase from 2018.
  • Pfizer annual income taxes for 2018 were $0.706B, a 107.8% decline from 2017.
  • Pfizer annual income taxes for 2017 were $-9.049B, a 905.79% decline from 2016.
Pfizer Annual Income Taxes
(Millions of US $)
2019 $1,384
2018 $706
2017 $-9,049
2016 $1,123
2015 $1,990
2014 $3,120
2013 $4,306
2012 $2,221
2011 $3,621
2010 $1,153
2009 $2,145
2008 $1,645
2007 $1,023
2006 $1,992
2005 $3,178
Pfizer Quarterly Income Taxes
(Millions of US $)
2020-09-30 $-26
2020-06-30 $519
2020-03-31 $475
2019-12-31 $-1,181
2019-09-30 $3,047
2019-06-30 $-915
2019-03-31 $433
2018-12-31 $-564
2018-09-30 $66
2018-06-30 $648
2018-03-31 $556
2017-12-31 $-11,336
2017-09-30 $727
2017-06-30 $739
2017-03-31 $821
2016-12-31 $14
2016-09-30 $249
2016-06-30 $347
2016-03-31 $513
2015-12-31 $-188
2015-09-30 $567
2015-06-30 $905
2015-03-31 $706
2014-12-31 $545
2014-09-30 $911
2014-06-30 $1,082
2014-03-31 $582
2013-12-31 $430
2013-09-30 $985
2013-06-30 $1,782
2013-03-31 $1,109
2012-12-31 $513
2012-09-30 $-183
2012-06-30 $1,180
2012-03-31 $711
2011-12-31 $434
2011-09-30 $1,216
2011-06-30 $1,077
2011-03-31 $894
2010-12-31 $-2,012
2010-09-30 $558
2010-06-30 $1,472
2010-03-31 $1,135
2009-12-31 $-807
2009-09-30 $1,092
2009-06-30 $786
2009-03-31 $1,074
2008-12-31 $394
2008-09-30 $463
2008-06-30 $25
2008-03-31 $763
2007-12-31 $223
2007-09-30 $-161
2007-06-30 $272
2007-03-31 $689
2006-12-31 $223
2006-09-30 $717
2006-06-30 $790
2006-03-31 $262
2005-12-31 $477
2005-09-30 $530
2005-06-30 $-464
2005-03-31 $2,635
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $206.939B $51.750B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $379.086B 17.89
Roche Holding AG (RHHBY) Switzerland $285.787B 0.00
Novartis AG (NVS) Switzerland $205.434B 15.66
Merck (MRK) United States $202.049B 13.84
AbbVie (ABBV) United States $185.181B 10.70
Novo Nordisk (NVO) Denmark $159.043B 25.39
Eli Lilly (LLY) United States $141.038B 21.34
AstraZeneca (AZN) United Kingdom $138.080B 27.26
Sanofi (SNY) $128.037B 15.22
GlaxoSmithKline (GSK) United Kingdom $92.991B 12.32
Bayer (BAYRY) Germany $55.438B 8.35
H Lundbeck (HLUYY) Denmark $6.160B 10.78
Innoviva (INVA) United States $1.100B 5.02